Entourage Health (CVE:ENTG) Reaches New 1-Year Low – Should You Sell?

Entourage Health Corp. (CVE:ENTGGet Free Report)’s share price hit a new 52-week low on Monday . The company traded as low as C$0.01 and last traded at C$0.01, with a volume of 21750 shares changing hands. The stock had previously closed at C$0.01.

Entourage Health Stock Performance

The company has a quick ratio of 0.91, a current ratio of 0.10 and a debt-to-equity ratio of 2,914.72. The firm has a market cap of C$3.08 million, a price-to-earnings ratio of -0.07 and a beta of 1.08. The business’s fifty day moving average is C$0.01 and its two-hundred day moving average is C$0.01.

About Entourage Health

(Get Free Report)

Entourage Health Corp. processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. It offers cannabis products, such as dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary’s Medicinals, and Royal City Cannabis brand names.

Read More

Receive News & Ratings for Entourage Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entourage Health and related companies with MarketBeat.com's FREE daily email newsletter.